PoLoPo team

© PoLoPo

Plant Cell Cultivation

PoLoPo Expands Lab Capacity, Completes Successful Outdoor Field Trial of Protein-Producing Potatoes

PoLoPo, a company specializing in molecular farming, has announced two key developments: a successful field trial producing five tons of protein-rich potatoes and the expansion of its lab capabilities to meet growing demand for protein samples. The company’s trial, which exceeded initial expectations by yielding approximately five tons of potatoes—two tons more than anticipated—marks a significant milestone in its efforts to scale production of functional proteins. These potatoes are engineered to contain both ovalbumin and patatin, a protein native to the plant. Despite being genetically engineered, the protein powder derived from these potatoes contains no genetic material and is classified as non-GMO. In addition to the field trial success, PoLoPo has upgraded its laboratory facilities, enabling it to supply hundreds of grams of protein powders …

more

Molecular farming startup PoLoPo announces that it will start supplying one of its flagship proteins, patatin, for F&B products to commercial clients, pending USDA's regulatory approval.

© PoLoPo

Company News

Unexpected Demand for Affordable Patatin Pushes Molecular Farming Startup PoLoPo to Prioritize Product Launch

Molecular farming startup PoLoPo announces that it will start supplying one of its flagship proteins, patatin, for F&B products to commercial clients, pending the USDA’s regulatory approval. The Israeli startup has developed a platform to grow the egg protein ovalbumin, widely used in the food industry, and patatin in large volumes in potato tubers, securing a lower cost. As explained by the startup, patatin, the native protein of potatoes, is expected to have a relatively straightforward regulatory process. Despite being derived from genetically engineered plants, it is extracted and processed into a powder that contains no genetic material, making it non-GMO. CEO and co-founder Maya Sapir-Mir comments, “We are keeping our eyes on the prize, which is bringing molecular-farmed egg protein to market, but conversations …

more